Publications by authors named "Klaus Rudolf"

Claim this Profile
F
Fingertip and Thumb Tip Wounds: Changing Algorithms for Sensation, Aesthetics, and Function.
Günter Germann, Klaus D Rudolf, Scott L Levin, Manuel Hrabowski

J Hand Surg Am· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibition.
Gerald J Roth, Armin Heckel, Jörg T Kley, Thorsten Lehmann, Stephan G Müller, Klaus Rudolf

Bioorg Med Chem Lett· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part III: Discovery of pre-clinical development candidate BI 186908.
Thorsten Oost, Armin Heckel, Jörg T Kley, Thorsten Lehmann, Stephan Müller, Klaus Rudolf

Bioorg Med Chem Lett· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part I: Optimization of HTS hits towards an in vivo efficacious tool compound BI 414.
Stephan G Müller, Armin Heckel, Jörg T Kley, Thorsten Lehmann, Philipp Lustenberger, Klaus Rudolf

Bioorg Med Chem Lett· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of thumb tip injuries.
Günter Germann, Michael Sauerbier, Klaus D Rudolf, Manuel Hrabowski

J Hand Surg Am· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacy.
Thierry Bouyssou, Christoph Hoenke, Klaus Rudolf, Philipp Lustenberger, Sabine Pestel

Bioorg Med Chem Lett· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of 5-hydroxy-4H-benzo[1,4]oxazin-3-ones as beta2-adrenoceptor agonists.
Christoph Hoenke, Thierry Bouyssou, Christofer S Tautermann, Klaus Rudolf, Andreas Schnapp

Bioorg Med Chem Lett· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies towards topical selective beta2-adrenoceptor agonists with a long duration of action.
Thierry Bouyssou, Klaus Rudolf, Christoph Hoenke, Philipp Lustenberger, Andreas Schnapp

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microspectrometer based on holographically recorded diffractive elements using supplementary holograms.
Robert Brunner, Matthias Burkhardt, Klaus Rudolf, Nico Correns

Opt Express· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CGRP antagonists: unravelling the role of CGRP in migraine.
Henri Doods, Kirsten Arndt, Klaus Rudolf, Stefan Just

Trends Pharmacol Sci· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraine.
Klaus Rudolf, Wolfgang Eberlein, Wolfhard Engel, Helmut Pieper, Michael Entzeroth

J Med Chem· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis